Stryker has appointed Mike Carlin to lead its digital and robotics business. Spencer Stiles, Stryker’s group president of ...

Stryker has received 510(k) clearance from the FDA for its Incompass Total Ankle System, a next-generation implant targeting ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System.

Suryakumar Yadav surprised fans with a health update on Wednesday, June 25. From a Munich hospital bed, SYK shared an ...

Stryker just received FDA clearance for its Incompass® Total Ankle System, reinforcing its drive for surgical innovation and ...

Stryker stock is trading -6.87% below its average target price of $421.46 after marking a 1.6% during today's afternoon ...

This was the stock's fourth consecutive day of gains.

Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over the ...

StrykerSYK saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 64 to 71. Please watch the video at Investors.com - Stock Market Exposure: How To Make ...

Stryker (NYSE:SYK) announced today that it received FDA 510(k) clearance for its Incompass total ankle system.

Gross margins declined to 66.4% in the first quarter from 67.6% a year ago due to increased depreciation, a higher mix of ...

New York-based Formation Bio, an AI-native pharma company focused on accelerating drug development, revealed that its ...